Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma

Fig. 3

Probabilities of intracranial control (left) and overall survival patients receiving a standard radiation dose (60 Gy radiotherapy [RT]) and those receiving dose-escalated radiotherapy (66 Gy RT) after propensity-scored matching. Median OS: 457 days (60 Gy) versus 535 days (66 Gy), p = 0.023. Median time to intracranial relapse: 225 days (60 Gy) versus 301 days (66 Gy), p = 0.09

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us